Helius Medical Technologies, Inc. (HSDT): Price/Earnings to Growth Ratio

Corporate company logo of heliusmedical.com (HSDT)

Helius Medical develops wearable systems for the rehabilitation of patients with MS and stroke survivors, while on the GURU.Markets platform, the PEG fair value dynamics reflect market trends where 0.00 serves as the current parameter value. Tongue stimulation technology restores lost balance, and the stable operation of automated assembly lines ensures the timely fulfillment of all customer orders.

heliusmedical.com (HSDT): Price/Earnings to Growth Multiple from 07/04/2022 to 11/10/2026

Helius Medical (HSDT) - metric breakdowns and financial figures

- current quotes and average value forecast:
Fundamental company analysis:HSDT (Helius Medical Technologies, Inc.)
Core merchandise of Helius Medical Technologies

The PEG ratio compares the market value of earnings with their growth rate to identify undervalued assets. This metric serves as a filter to weed out overbought securities during long-term portfolio construction. Analyzing the P/E ratio divided by the growth rate allows for the detection of a fundamental discount. This is critical for Helius Medical (HSDT), as the company focuses on the organic expansion of its clinic network. The absence of mergers makes organic earnings growth the primary driver of capitalization.

Competing companies

BIIB - Price to Earnings Adjusted for Growth Rate|Price/Earnings to Growth Ratio Neurocrine Biosciences Inc NBIX|Regencell Corp - Price/Earnings to Growth Ratio|Axsome Therapeutics - PEG Multiple|Growth-Adjusted Market Cap to Net Income acadia-pharm.com ACAD|XENE (Xenon) - Price/Earnings to Growth Multiple|Viking Therapeutics Inc (VKTX) - PEG Multiple|Price/Earnings to Growth Ratio Supernus Pharma|Catalyst Corp (CPRX) - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Multiple DNLI (Denali Therapeutics)|HRMY (harmonybiosciences.com) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Biohaven BHVN|AMLX - Price/Earnings to Growth Multiple|Trevi Pharma - PEG Multiple|Price to Earnings Adjusted for Growth Rate Praxis Corp|AVXL: PEG Multiple|Growth-Adjusted P/E Ratio CBLL|PRTA (Prothena Corporation plc) - PEG Multiple|Alector Therapeutics (ALEC) - Growth-Adjusted Market Cap to Net Income|PEG Multiple ANNX|Price/Earnings to Growth Multiple omeros.com OMER|PEG Multiple NGNE (Neurogene Inc.)|PEG Multiple acimmune.com ACIU|VYGR - Price/Earnings to Growth Ratio|NMRA: Price/Earnings to Growth Ratio|SCLX: PEG Multiple|Tevogen Bio Inc. - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Alpha Cognition Inc|cogrx.com (CGTX) - Growth-Adjusted Market Cap to Net Income|PEG Multiple IKT|Cassava Sciences Inc - Growth-Adjusted P/E Ratio|Assertio - Price/Earnings to Growth Multiple|Company Value to Earnings Growth Ratio COYA (Coya Therapeutics Inc)|VTGN - Price/Earnings to Growth Ratio|OVID (Ovid Therapeutics Inc.) - Growth-Adjusted P/E Ratio|ABOS: PEG Multiple|Price to Earnings Adjusted for Growth Rate CervoMed, Inc. (CRVO)|Price/Earnings to Growth Multiple ATHE|PEG Multiple Clene Nanomedicine|Price/Earnings to Growth Ratio PepGen Inc. (PEPG)|JUNS (jupiterneurosciences.com) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Relmada Therapeutics, Inc. RLMD|Annovis Bio Inc (ANVS) - Price to Earnings Adjusted for Growth Rate|Grace Tx - PEG Multiple|Growth-Adjusted Payback Ratio AIFF (Firefly Neuro)|KLTO: PEG Multiple|Price to Earnings Adjusted for Growth Rate NeuroSense Therapeutics Ltd. (NRSN)|Price/Earnings to Growth Ratio Reviva Pharmaceuticals Holdings, Inc.|Price/Earnings to Growth Ratio MTVA|PEG Multiple NRXS|Growth-Adjusted Market Cap to Net Income passagebio.com|Neuphoria Therapeutics - Price/Earnings to Growth Multiple|PEG Multiple minervaneurosciences.com NERV|ATHA - Price/Earnings to Growth Ratio|Growth-Adjusted Market Cap to Net Income Addex Therapeutics Ltd. ADXN|ALZN (alzamend.com) - Price/Earnings to Growth Multiple|Cyclerion Therapeutics, Inc. - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Protagenic Therapeutics Inc.|Price/Earnings to Growth Multiple Pasithea (KTTA)|PEG Multiple CRGT|ATXI - Price to Earnings Adjusted for Growth Rate|PEG Multiple BCLI (Brainstorm Cell Therapeutics, Inc.)|CARA: Growth-Adjusted P/E Ratio|Chromocell Therapeutics - PEG Multiple|Growth-Adjusted Market Cap to Net Income Eliem Therapeutics ELYM|ITCI: PEG Multiple|Price/Earnings to Growth Multiple Longboard Pharmaceuticals Inc|MRNS (Marinus) - PEG Multiple|PEG Multiple NKGen Biotech Corp|Price/Earnings to Growth Ratio NeuroBo Pharmaceuticals (NRBO)|Price/Earnings to Growth Ratio SAGE (sagerx.com)|PEG Multiple SNPX (Synaptogenix)|Growth-Adjusted Payback Ratio TRVN|VIGL - Price/Earnings to Growth Ratio|Growth-Adjusted Market Cap to Net Income Anew Medical Inc. WENA|CERE: PEG Multiple